Avenir Wellness Solutions (Avenir Wellness Solutions) COGS-to-Revenue : 0.27 (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Avenir Wellness Solutions COGS-to-Revenue?

Avenir Wellness Solutions's Cost of Goods Sold for the three months ended in Sep. 2023 was $0.28 Mil. Its Revenue for the three months ended in Sep. 2023 was $1.02 Mil.

Avenir Wellness Solutions's COGS to Revenue for the three months ended in Sep. 2023 was 0.27.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Avenir Wellness Solutions's Gross Margin % for the three months ended in Sep. 2023 was 72.61%.

Avenir Wellness Solutions COGS-to-Revenue Historical Data

The historical data trend for Avenir Wellness Solutions's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avenir Wellness Solutions COGS-to-Revenue Chart

Avenir Wellness Solutions Annual Data

Trend

Mar15

Mar16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.48

0.37

0.52

0.29

0.32

Avenir Wellness Solutions Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
COGS-to-Revenue	Get a 7-Day Free Trial															0.20	0.78	0.21	0.29	0.27

Avenir Wellness Solutions COGS-to-Revenue Calculation

Avenir Wellness Solutions's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.557	/	4.896
	=	0.32

Avenir Wellness Solutions's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.278	/	1.015
	=	0.27

Avenir Wellness Solutions (OTCPK:AVRW) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Avenir Wellness Solutions's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.278 / 1.015
	=	72.61 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Avenir Wellness Solutions COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Avenir Wellness Solutions's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Avenir Wellness Solutions (Avenir Wellness Solutions) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avenir Wellness Solutions Inc (OTCPK:AVRW) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

5805 Sepulveda Boulevard, Suite 801, Sherman Oaks, CA, USA, 91411

Website

https://www.avenirwellness.com

Avenir Wellness Solutions Inc is a broad wellness platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on approximately 15 current patents, offers several immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The company sells its product under the brand names Seratopical, Seratopical Revolution, SeraLabs, and Nutri-Strips.

Executives

Robert J Costantino	director	5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Joel M Bennett	officer: CFO,CAO, Treasurer & Secretary	22619 PACIFIC COAST HIGHWAY, MALIBU CA 90265
Gerald Bagg	director	C/O CURE PHARMACEUTICAL HOLDING CORP., 5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Nancy Duitch	officer: Chief Strat Officer-Wellness	15950 ROYAL OAK RD, ENCINO CA 91436
Robert Steven Davidson	director, officer: CEO & Director	5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Jonathan Berlent	officer: Chief Business Officer	1620 BEACON PLACE, OXNARD CA 93033
John K Bell	director	38 FALLBROOK LANE RR 33, CAMBRIDGE A6 N3H 4R8
Anna Goldin	director	1620 BEACON STREET, OXNARD CA 93033
Lauren Chung	director	1620 BEACON STREET, OXNARD CA 93033
Michael Redard	officer: Chief Financial Officer	1620 BEACON PLACE, OXNARD CA 93033
Joshua Held	director	1620 BEACON PLACE, OXNARD CA 93033
Climate Change Investigation, Innovation & Investment Company, Llc	10 percent owner	12 SAN RAFAEL AVE, BELVEDERE CA 94920
Ruben Jr King-shaw	director	1620 BEACON PLACE, OXNARD CA 93033
Gene Z Salkind	director	5805 SEPULVEDA BLVD., SUITE 801, SHERMAN OAKS CA 91411
Alex Katz	officer: CFO	1233 FAIRY HILL ROAD, RYDAL PA 19046